Veronika Binder et al.
Arteriosclerosis, thrombosis, and vascular biology, 33(5), 1020-1027 (2013-03-16)
Elevated levels of advanced oxidation protein products have been described in several chronic inflammatory diseases, like chronic renal insufficiency, rheumatoid arthritis, and atherosclerosis. Recent findings revealed that advanced oxidation protein products are inhibitors of the major high-density lipoprotein receptor, scavenger